http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-202220977-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b5454abd09f216530c44daae0e81afa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a36c66685971b78daf233b5999ead4c2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-075
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
filingDate 2021-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e165707460153fbf929dd3d065afb1a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1ed5a8d62b9e05139673d9e985c07d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2001c17cb49cfe79cf0dacae58c64da3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_241c5af93f68ed701a5b4ac48b3001c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac4093f3e1058bc586c828f9a034bf71
publicationDate 2022-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-202220977-A
titleOfInvention 6-oxo-1,6-dihydropyridazine derivative, preparation method therefor and application thereof in medicine
abstract The present application provides a 6-oxo-1,6-dihydropyridazine derivative, a preparation method therefor and an application thereof in medicine. Specifically, the present application provides a 6-oxo-1,6-dihydropyridazine derivative as represented by formula (I), a preparation method therefor, a pharmaceutical composition comprising the derivative, and an application of the derivative as a therapeutic agent, particularly the use of same in the preparation of a drug for treating or preventing diseases regulated by thyroid hormones, wherein substituents in the formula have the same definitions as those in the description.
priorityDate 2020-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407318370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68153

Total number of triples: 27.